TY  - JOUR 
AU  - Aldred, Jason
AU  - Anca-Herschkovitsch, Marieta
AU  - Antonini, Angelo
AU  - Bajenaru, Ovidiu
AU  - Bourgeois, Paul
AU  - Cubo Delgado, Esther
AU  - Davis, Thomas L.
AU  - Iansek, Robert
AU  - Kovács, Norbert
AU  - Kukreja, Pavnit
AU  - Onuk, Koray
AU  - Pontieri, Francesco E.
AU  - Robieson, Weining
AU  - Siddiqui, Mustafa S.
AU  - Simu, Mihaela
AU  - Standaert, David G.
AU  - Chaudhuri, K. Ray
PY  - 2020
SN  - 1758-2024
UR  - http://hdl.handle.net/10259/8797
AB  - Aim: A Delphi expert consensus panel proposed that fulfilling ≥1 of the ‘5-2-1 criteria’ (≥five-times daily oral levodopa use, ≥two daily hours with ‘Off’ symptoms or ≥one daily hour with troublesome dyskinesia) suggests advanced Parkinson’s disease...
LA  - eng
PB  - Future Medicine
KW  - 5-2-1
KW  - Criteria for advanced PD
KW  - Dyskinesia
KW  - LCIG
KW  - Levodopa
KW  - Levodopa-carbidopa intestinal gel
KW  - Off time
KW  - Parkinson’s disease
KW  - Sistema nervioso-Enfermedades
KW  - Nervous system-Diseases
KW  - Medicina
KW  - Medicine
KW  - Neurología
KW  - Neurology
TI  - Application of the ‘5-2-1’ screening criteria in advanced Parkinson’s disease: interim analysis of DUOGLOBE
DO  - 10.2217/nmt-2020-0021
T2  - Neurodegenerative Disease Management
VL  - 10
M2  - 309
ER  -